Literature DB >> 8782648

Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan.

L Y Wang1, M Hatch, C J Chen, B Levin, S L You, S N Lu, M H Wu, W P Wu, L W Wang, Q Wang, G T Huang, P M Yang, H S Lee, R M Santella.   

Abstract

To investigate the carcinogenic effect of environmental aflatoxin exposure, 56 cases of hepatocellular carcinoma (HCC) diagnosed between 1991 and 1995 were identified and individually matched by age, sex, residence and date of recruitment to 220 healthy controls from the same large cohort in Taiwan. Blood samples were analyzed for hepatitis B and C viral markers and for aflatoxin-albumin adducts; urine was tested for aflatoxin metabolites. We obtained information about sociodemographic characteristics, habitual alcohol drinking, cigarette smoking and diet in a structured interview. Hepatitis B virus surface antigen (HBsAg) carriers had a significantly increased risk for HCC. After adjustment for HBsAg serostatus, the matched odds ratio (ORm) was significantly elevated for subjects with high levels of urinary aflatoxin metabolites. When stratified into tertiles, a dose-response relationship with HCC was observed. The ORm for detectable aflatoxin-albumin adducts was not significant after adjustment for HBsAg serostatus. HBsAg-seropositive subjects with high aflatoxin exposure had a higher risk than subjects with high aflatoxin exposure only or HBsAg seropositivity only. In male HBsAg-seropositive subjects, adjusted ORs were 2.8 (95% confidence interval [CI] = 0.9-9.1) for detectable compared with non-detectable aflatoxin-albumin adducts and 5.5 (CI = 1.3-23.4) for high compared with low urinary aflatoxin metabolite levels. Our results suggest that environmental aflatoxin exposure may enhance the hepatic carcinogenic potential of hepatitis B virus. A large-scale study will be needed to evaluate the effect of aflatoxin exposure on HBsAg non-carriers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8782648     DOI: 10.1002/(SICI)1097-0215(19960904)67:5<620::AID-IJC5>3.0.CO;2-W

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  56 in total

1.  Chemopreventive effect of oltipraz on AFB(1)-induced hepatocarcinogenesis in tree shrew model.

Authors:  Yuan Li; Jian-Jia Su; Liu-Liang Qin; Chun Yang; Dan Luo; Ke-Chen Ban; TW Kensler; BD Roebuck
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: Results from a large, community-based screening, evaluation, and treatment program.

Authors:  Henry J Pollack; Simona C Kwon; Su H Wang; Laura C Wyatt; Chau Trinh-Shevrin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11       Impact factor: 4.254

Review 3.  Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis.

Authors:  Yan Liu; Chung-Chou H Chang; Gary M Marsh; Felicia Wu
Journal:  Eur J Cancer       Date:  2012-03-08       Impact factor: 9.162

4.  Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma.

Authors:  Yu-Jing Zhang
Journal:  World J Hepatol       Date:  2010-03-27

5.  Polycyclic aromatic hydrocarbon- and aflatoxin-albumin adducts, hepatitis B virus infection and hepatocellular carcinoma in Taiwan.

Authors:  Hui-Chen Wu; Qiao Wang; Lian-Wen Wang; Hwai-I Yang; Habibul Ahsan; Wei-Yann Tsai; Li-Yu Wang; Shu-Yuan Chen; Chien-Jen Chen; Regina M Santella
Journal:  Cancer Lett       Date:  2007-01-23       Impact factor: 8.679

6.  Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study.

Authors:  Hui-Chen Wu; Qiao Wang; Hwai-I Yang; Wei-Yann Tsai; Chien-Jen Chen; Regina M Santella
Journal:  Carcinogenesis       Date:  2012-05-12       Impact factor: 4.944

7.  Aflatoxin B1 exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers.

Authors:  Yu-Ju Chu; Hwai-I Yang; Hui-Chen Wu; Jessica Liu; Li-Yu Wang; Sheng-Nan Lu; Mei-Hsuan Lee; Chin-Lan Jen; San-Lin You; Regina M Santella; Chien-Jen Chen
Journal:  Int J Cancer       Date:  2017-05-26       Impact factor: 7.396

8.  Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan.

Authors:  Hui-Chen Wu; Jing Shen; Hwai-I Yang; Wei-Yann Tsai; Chien-Jen Chen; Regina M Santella
Journal:  World J Hepatol       Date:  2016-02-18

9.  Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma.

Authors:  Zhi-Ming Liu; Le-Qun Li; Min-Hao Peng; Tang-Wei Liu; Zhong Qin; Ya Guo; Kai-Yin Xiao; Xin-Ping Ye; Xin-Shao Mo; Xue Qin; Shan Li; Lu-Nan Yan; Han-Ming Shen; LianWen Wang; Qiao Wang; Kai-bo Wang; Ren-xiang Liang; Zong-liang Wei; Choon Nam Ong; Regina M Santella; Tao Peng
Journal:  Cancer Lett       Date:  2008-02-15       Impact factor: 8.679

10.  Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan.

Authors:  Hui-Chen Wu; Qiao Wang; Hwai-I Yang; Habibul Ahsan; Wei-Yann Tsai; Li-Yu Wang; Shu-Yuan Chen; Chien-Jen Chen; Regina M Santella
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.